Multiple chemical sensitivities syndrome: toward a working case definition

Archives of Environmental Health
J R NethercottH Abbey

Abstract

A study was conducted to identify clinical diagnostic criteria that experts regarded as major for categorizing patients as having multiple chemical sensitivities (MCS) syndrome. A cross-sectional survey of 148 medical practitioners with an interest in, or familiarity with, the condition was performed scoreable questionnaires were returned by 60.1% of those surveyed. The following five criteria, all based on self-reports, were selected as major for diagnosing the syndrome by more than 50% of the respondents: (1) symptoms are reproducible with exposure; (2) condition is chronic; (3) low levels of exposure result in manifestations of the syndrome; (4) symptoms resolve with removal of incitants; and (5) responses occur to multiple, chemically unrelated substances. It is proposed that the major criteria accepted by the majority of survey respondents be used provisionally as the basis for categorizing cases in investigations of MCS syndrome.

References

Jul 1, 1990·Archives of Environmental Health·J D ThrasherR Madison
Mar 1, 1989·Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association·A I Terr
Jan 1, 1986·Archives of Internal Medicine·A I Terr
May 1, 1983·Archives of Otolaryngology·J J McGovernP Cleary
Aug 1, 1983·Psychosomatics·C M Brodsky

❮ Previous
Next ❯

Citations

Jan 1, 1994·International Archives of Occupational and Environmental Health·C Wolf
Jan 1, 2003·Environmental Health and Preventive Medicine·Mitsuyasu WatanabeYoshiharu Aizawa
Jan 1, 2003·Environmental Health and Preventive Medicine·Mitsuyasu WatanabeYoshiharu Aizawa
Jul 16, 2009·Environmental Health and Preventive Medicine·Sachiko HojoHiroaki Kumano
Oct 23, 1997·Journal of Psychosomatic Research·K GuptaJ P Watson
Mar 20, 1998·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·I R BellJ M Peterson
Mar 1, 2002·Toxicology Letters·Chris Winder
Mar 1, 2002·Toxicology Letters·Hermann M Bolt, Ernst Kiesswetter
Dec 1, 1996·American Journal of Contact Dermatitis : Official Journal of the American Contact Dermatitis Society·B A Brod
Oct 15, 1996·Environmental Toxicology and Pharmacology·L Fishbein
Aug 2, 2001·Archives of Environmental Health·D J Kutsogiannis, A L Davidoff
Jan 5, 2002·Archives of Environmental Health·G E McKeown-EyssenE R Sokoloff
Jan 1, 2003·Archives of Environmental Health·Gerhard Andreas WiesmüllerAndreas Seeber
Aug 12, 1999·Archives of Environmental Health
Jul 18, 2006·Health Care for Women International·Juliene G Lipson, Nathalie Doiron
Jan 3, 2001·Environmental Health Perspectives·A Woolf
Aug 27, 2002·Environmental Health Perspectives·Glenn J Greene, Howard M Kipen
Mar 1, 1997·Environmental Health Perspectives·T Eissenberg, R R Griffiths
Aug 21, 2013·PloS One·Marie Thi Dao TranSusan Hovmand Lysdal
Sep 29, 1998·American Family Physician·M K Magill, A Suruda
Jun 24, 2008·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Susanne BornscheinThomas Zilker
Jun 1, 1995·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·L M Howard, S Wessely
Apr 11, 2012·International Journal of Hygiene and Environmental Health·Marie Thi Dao TranJesper Elberling
Apr 29, 2015·International Archives of Occupational and Environmental Health·Linus AnderssonSteven Nordin
May 27, 2008·International Journal of Hygiene and Environmental Health·Dieter EisMargitta Worm
Dec 25, 2007·International Journal of Hygiene and Environmental Health·Sachiko HojoKou Sakabe
Jun 24, 2005·International Journal of Hygiene and Environmental Health·Michael LacourCarl Scheidt
Jun 21, 2005·Psychoneuroendocrinology·Bente E Moen
Sep 18, 1999·Lancet·S WesselyM Sharpe
May 18, 1999·Preventive Medicine·P M RossG M Williams

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.